Industry ranking
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2024 - 31 Dec 2024 | 13 Feb 2025 | 26 | 75% | 23% | 2% | 3% |
| 01 Jan 2024 - 30 Jun 2024 | 13 Feb 2025 | 38 | 48% | 38% | 14% | 2% |
| 01 Jul 2023 - 31 Dec 2023 | 29 May 2024 | 61 | 23% | 35% | 42% | 3% |
| 01 Jan 2018 - 30 Jun 2018 | 31 Jul 2018 | 46 | 25% | 58% | 17% | 1% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
30 days payment unless specified on supplier invoice.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
The end user is responsible to contact the supplier to raise any queries and request credit note if required.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Bio-Techne Ltd is the UK-registered entity within the Bio-Techne group, a global developer, manufacturer and supplier of research reagents, analytical instruments and precision diagnostics. The wider group provides antibodies, proteins, ELISA kits, RNAscope assays, spatial biology tools and diagnostic instruments used by academic researchers, biotechnology companies and clinical laboratories, alongside contract development and manufacturing services and quality controls for diagnostics. This UK company forms part of that group's operations, supporting the supply and distribution of these life science and diagnostic products. Company records list its nature of business as non-specialised wholesale trade, reflecting its role in distributing the group's scientific and diagnostic products within the UK market.
Generated from the company's website and Companies House records. Sources: biotechne.com · biotechne.com